Examples of 'mifamurtide' in a sentence
Meaning of "mifamurtide"
mifamurtide (noun) - This phrase refers to a drug used in the treatment of osteosarcoma, a type of bone cancer. It is used in the context of oncology and pharmaceuticals
Show more definitions
- A drug, having a phospholipid moiety, used to treat osteosarcoma.
How to use "mifamurtide" in a sentence
Basic
Advanced
mifamurtide
It is unknown whether mifamurtide is excreted in human milk.
It contains the active substance mifamurtide.
The excretion of mifamurtide in milk has not been studied in animals.
The active substance is mifamurtide.
Mifamurtide treatment was continued for the remainder of the study without seizure recurrence.
There are no data from the use of mifamurtide in pregnant women.
Mifamurtide was not mutagenic and did not cause teratogenic effects in rats and rabbits.
This medicine should not be used in combination with mifamurtide.
Limited studies of the interaction of mifamurtide with chemotherapy have been conducted.
However, mifamurtide can be coadministered with low doses of NSAIDs.
These data indicate that neither total nor free mifamurtide accumulated during the treatment period.
Powder for concentrate for dispersion for infusion 4 mg mifamurtide.
Anaemia has very commonly been reported when mifamurtide is used in conjunction with chemotherapeutic agents.
Mifamurtide simulates a bacterial infection by binding to NOD2, activating white cells.
Vial of MEPACT mifamurtide.
See also
Association of mifamurtide with signs of pronounced inflammatory response, including pericarditis and pleuritis, was uncommon.
High-dose NSAIDs block the mechanism of mifamurtide in vitro.
Consequently, the combination of mifamurtide with these types of drugs is contraindicated.
What MEPACT contains - The active substance is mifamurtide.
The recommended dose of mifamurtide for all patients is 2 mg / m body surface area.
One vial contains 4 mg mifamurtide.
The safety and efficacy of mifamurtide in children aged 0 to 2 years have not been established.
Each vial contains 4 mg of mifamurtide.
The recommended dose of mifamurtide for all patients is 2 mg/m2 body surface area.
No dedicated fertility studies have been conducted with mifamurtide see section 5.3.
No-adverse-effect level for mifamurtide in animals corresponds roughly to the 2 mg/m2 recommend dose for humans.
Nausea, vomiting and loss of appetite are very common adverse reactions to mifamurtide see section 4.8.
If a severe respiratory reaction occurs, administration of mifamurtide should be discontinued and appropriate treatment initiated.
One drug that was tested is the immunotherapy drug called mifamurtide ( Mepact ).
LINES / MEMOS, Linsitinib in advanced Ewing 's sarcoma and Mifamurtide in advanced osteosarcoma.
After reconstitution, each ml of suspension in the vial contains 0.08 mg mifamurtide.
Hyperhidrosis ( 11 % ) was very common in patients receiving mifamurtide in uncontrolled studies.
After reconstitution, each ml of reconstituted suspension in the vial contains 0.08 mg of mifamurtide.
IDM Pharma was acquired by Takeda along with mifamurtide in June 2009.
Anorexia ( 21 % ) was very commonly reported in phase I and II studies of mifamurtide.
Skin and subcutaneous disorders Hyperhidrosis ( 11 % ) was very common in patients receiving mifamurtide in uncontrolled studies.
